Site Search
Professionals 471 results
Capabilities 58 results
Practice Area
Our Patent Litigation Practice is one of the country’s most active and highly regarded. Our seasoned patent litigators bring extensive courtroom experience to every matter we handle. According to Lex Machina, we are among the top three national patent defense firms in the country for number of appearances and cases filed, and we also were the top national defense firm for number of patent trials in the last five years (2018–2022).
Practice Area
eDiscovery & Information Governance
Winston’s eDiscovery & Information Governance Practice (eDiscovery Group) is one of the United States’ largest and most experienced. Per The Legal 500 US 2024, “[Winston has] a very strong practice from top to bottom. They have a good e-discovery consulting practice and excellent review and production capabilities and are amongst the strongest advocates you could want in a courtroom.” We have built a full-service consulting practice to support our clients and case teams in these complex areas—both domestically and globally.
Practice Area
Winston is a global powerhouse in the restructuring and insolvency space. We offer a fully integrated team of attorneys across a global platform to guide clients through any distressed situation, whether the client is a savvy and interested investor, a creditor seeking to maximize its recovery, or a company aiming to proceed through a successful yet complex restructuring. We have advised stakeholders in some of the highest-profile restructurings and bankruptcy cases in the United States and beyond, including Caesars Entertainment, ResCap, the Los Angeles Dodgers, Enron, Lehman Brothers, Pacific Gas & Electric, LATAM Airlines, and the Commonwealth of Puerto Rico, among others.
Experience 32 results
Experience
|May 10, 2024
Winston’s London Restructuring practice scores a significant win on appeal for Hong Kong and BVI liquidator claimants in the People’s Republic of China (PRC) based Peking University Founders Group Limited (PUFG) insolvency.
Experience
|July 6, 2023
Experience
|April 28, 2023
Secured New CBA Deal for NBA Players Following Round-the-Clock Negotiating Sessions with NBA
Insights & News 896 results
Seminar/CLE
|May 13, 2025
2025 Health Care & Life Sciences Summit
Winston & Strawn is pleased to host its fifth annual Health Care & Life Sciences Summit. Clients and friends of the firm are invited to join us to network with peers and gain insights from industry leaders and legal experts. The summit will take place live at our Chicago office, and CLE-eligible recordings of the Summit’s sessions will be available shortly following the event.
Class Action Insider
|May 2, 2025
|8 Min Read
Song–Beverly Act Reforms – Rebalancing Consumer Rights and OEM Responsibilities?
Since the 1970s, the Song–Beverly Consumer Warranty Act has protected buyers of potentially defective vehicles. The latest update, Assembly Bill 1755, aims to curb excessive lemon law litigation and speed up resolutions—but faced pushback from both consumer advocates and automakers, prompting a follow-up measure: Senate Bill 26.
Client Alert
|May 1, 2025
|3 Min Read
April 2025 Executive Order Targets Prescription Drug Price Reduction
On April 15, 2025, President Trump signed an executive order titled “Lowering Drug Prices by Once Again Putting Americans First.” The subject matter of this executive order criss-crosses considerable policy ground in the overall U.S. pharmaceutical distribution chain. The executive order sets forth the administration’s statement of objectives to reduce prescription medication costs by promoting competition and eliminating practices that lead to high drug prices. Referencing regulatory and policy actions from the first Trump administration and the Biden administration’s policy steps, including the Inflation Reduction Act of 2022 aimed at lowering prescription drug prices for Medicare beneficiaries, the executive order sets forth a broad agenda to impact Medicare prescription drug costs, including in the Medicare Part D program.[1] The order directs the Secretary of Health and Human Services (HHS) to propose and seek comment on guidance for the Medicare Drug Price Negotiation Program and collaborate with Congress to align the treatment of small molecule drugs with biological products, citing concerns about industry investment distortions and cost increases for Medicare and its beneficiaries.[2]
Other Results 26 results
Site Content
The Shipping Act is a set of maritime commerce regulations overseen by The Federal Maritime Commission (FMC). The Shipping Act of 1916 created the United States Shipping Board, the first federal agency tasked with regulating the U.S. maritime industry and addressing shipping shortages caused by World War I. It was later modified by the Shipping Act of 1984 in response to changes in the industry and more recently by the Ocean Shipping Reform Act of 2022. Today it remains foundational to regulating the U.S. commercial shipping industry.
Site Content
Location
Winston & Strawn’s Miami office opened in 2022 and represents the firm’s largest expansion in several years. Located in the heart of the city’s Financial District, the office launched with a strong team of transactional and litigation partners from prestigious law firms operating in South Florida. Our Miami office leverages the area’s status as a critical nexus point for banking and international trade with the United States, Europe, Latin America, and other parts of the world. Our attorneys have the cultural fluency and local knowledge necessary to work seamlessly with international clients, particularly those with ties to Latin America.